February 16, 2026
Reconsidering South Africa’s Medicine Pricing Framework
The regulation of pharmaceutical costs presents a persistent challenge for healthcare systems. South…
February 9, 2026
How Local Clinical Trials Accelerate Drug Access and Build Health System Resilience
How Local Clinical Trials Accelerate Drug Access and Build Health System Resilience For…
February 2, 2026
Ensuring Accuracy in Healthcare Valuation Verification
Ensuring Accuracy in Healthcare Valuation Verification A recent case in health economics underscores…
January 26, 2026
Composite NNT CPEA: True Value in CVD and CKM Therapies
Healthcare leaders can now use composite NNT CPEA to assess treatments more fully,…
January 19, 2026
Advancing LatAm COPD Access: Chiesi Group Strategies
LatAm COPD access stands at the forefront of regional healthcare challenges, where vast…
January 12, 2026
NICE QALY Thresholds Rise: Impacts on NHS Access
NICE QALY thresholds will increase from £20,000–£30,000 to £25,000–£35,000 per quality-adjusted life year…
